1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Connected Care in Europe

Connected Care in Europe

  • October 2014
  • -
  • Berg Insight AB
  • -
  • 123 pages

Executive summary
The ageing population and the increasing prevalence of chronic diseases will be two of the greatest challenges in Europe during this century. It is widely believed that connected care solutions can ease the burden on society by enabling more efficient delivery of care and allowing people to live independently in their homes for longer. Berg Insight’s definition of connected care comprises telecare and telehealth solutions that are used for the remote delivery of healthcare and social care services. Today, the most common connected care solution is the traditional telecare alarm, which includes a wearable alarm button that the user presses in the case of an emergency. Next-generation telecare systems are technologically more advanced and can automatically trigger an alarm, for instance if the user leaves home at an unexpected time or forgets to take his or her medicine. Furthermore, next-generation telecare solutions include mobile telecare alarms that users can carry with them at all times. Telehealth solutions involve connected medical devices and monitoring services that are used for the remote management of patients with COPD, chronic heart failure, diabetes, hypertension, asthma, coronary heart disease or chronic kidney disease.

Traditional telecare is the largest and most mature segment of the connected care market with a total of 4.55 million users at the end of 2013. In contrast to this, the markets for nextgeneration telecare and telehealth solutions are still in nascent stages. At the end of 2013, there were 0.69 million users of next-generation telecare solutions in EU28+2, whereas the number of telehealth users reached just 0.06 million. The total number of people using connected care solutions totalled 4.7 million at the end of 2013, as there is some overlap between the three solution categories. The market is forecasted to grow at a CAGR of 19.8 percent during the next six years to reach 13.7 million connected care users by 2019. Berg Insight expects that traditional telecare will remain the largest segment of the connected care market with 5.6 million users in 2019. However, traditional telecare will be closely followed by next-generation telecare and telehealth that are growing more quickly and will reach a forecasted 4.9 million users and 4.7 million users respectively at the end of the forecast period.

Table Of Contents

Connected Care in Europe
Table of Contents
Table of Contents . i
List of Figures v
Executive summary 1
1 Healthcare and social care in Europe 3
1.1 Introduction . 3
1.1.1 The ageing population 3
1.1.2 Metabolic syndrome and lifestyle related diseases . 5
1.2 Chronic diseases .. 6
1.2.1 Cardiovascular diseases 7
1.2.2 Hypertension 7
1.2.3 Chronic respiratory diseases .. 7
1.2.4 Diabetes . 8
1.3 Medical conditions .. 9
1.3.1 Autism .. 9
1.3.2 Dementia . 10
1.3.3 Epilepsy 10
1.3.4 Other cognitive and physical disabilities . 11
1.4 Healthcare and social care systems 11
1.4.1 Healthcare systems 12
1.4.2 Social care systems .. 15
1.5 The regulatory environment . 17
1.5.1 Medical device regulations 17
1.5.2 Privacy regulations . 18
2 Traditional telecare solutions 21
2.1 Market overview . 21
2.1.1 Form factors and use cases .. 22
2.1.2 Value chain . 23
2.1.3 Competitive landscape . 25
2.2 Solution providers . 27
2.2.1 Azur Soft .. 28
2.2.2 Bosch Healthcare 28
2.2.3 CareTech . 29
2.2.4 Centra Pulse .. 30
2.2.5 Chubb Community Care . 31
2.2.6 Eurocross 32
2.2.7 Jontek 32
2.2.8 Legrand 32
2.2.9 TBS Group .. 34
2.2.10 Tunstall Healthcare Group . 35
2.2.11 Verklizan .. 37
2.2.12 Urmet ATE .. 38
3 Next-generation telecare solutions 39
3.1 Market overview . 39
3.1.1 Form factors and use cases .. 40
3.1.2 Value chain . 44
3.1.3 Competitive landscape . 45
3.2 Solution providers . 46
3.2.1 Doro 47
3.2.2 Evermind . 49
3.2.3 Everon .. 49
3.2.4 Evondos .. 50
3.2.5 Essence Group . 52
3.2.6 Innospense . 53
3.2.7 Just Checking 54
3.2.8 KPN 55
3.2.9 Limmex . 56
3.2.10 Lively .. 58
3.2.11 LOSTnFOUND .. 58
3.2.12 Medicpen . 59
3.2.13 Merck Serono 60
3.2.14 Numera . 61
3.2.15 Oysta Technology .. 63
3.2.16 Telecom Design .. 64
3.2.17 Vivago 65
4 Telehealth solutions .. 69
4.1 Market overview . 69
4.1.1 Form factors and use cases .. 70
4.1.2 Value chain . 72
4.1.3 Competitive landscape . 74
4.2 Solution providers . 76
4.2.1 Alere .. 78
4.2.2 Apple HealthKit . 80
4.2.3 BePatient Solutions 81
4.2.4 BodyTel 81
4.2.5 BT Group . 82
4.2.6 Comarch .. 83
4.2.7 CSC Scandihealth .. 85
4.2.8 eDevice . 86
4.2.9 H2AD . 88
4.2.10 Hope Care .. 89
4.2.11 Medic4All . 90
4.2.12 Medixine .. 91
4.2.13 Medvivo 92
4.2.14 S3 Group . 93
4.2.15 SHL Telemedicine .. 94
4.2.16 SilverBullet .. 95
4.2.17 Swissmed Mobile 96
4.2.18 Qualcomm Life . 97
4.2.19 Telbios .. 98
4.2.20 Telefónica 99
4.2.21 Vitaphone . 101
4.2.22 Voluntis .. 102
5 Market forecasts and conclusions .. 105
5.1 Market trends and analysis 105
5.1.1 PSTN network digitalization drives transition to IP-based telecare systems . 106
5.1.2 Millions of new cellular connections will be needed for connected care 107
5.1.3 Next-generation activity monitoring solutions enable new use cases .. 108
5.1.4 Technological developments will affect the competitive landscape .. 109
5.1.5 Convergence between telecare and telehealth 109
5.1.6 BYOD will become a viable option for telehealth . 110
5.1.7 The medication compliance monitoring market gains momentum in Europe . 112
5.1.8 The interest in mobile telecare solutions is growing .. 113
5.2 Market forecasts .. 114
5.2.1 Traditional telecare .. 115
5.2.2 Next-generation telecare .. 116
5.2.3 Telehealth . 117
5.3 Revenue forecasts .. 119
5.3.1 Traditional telecare .. 119
5.3.2 Next-generation telecare .. 120
5.3.3 Telehealth . 121
Glossary . 123
Index

List of Figures
Figure 1.1: Population by age group (EU28+2 2013-2030) 4
Figure 1.2: Number of people suffering from various chronic diseases (EU28+2 2012) . 6
Figure 1.3: Number of people suffering from various medical conditions (EU 2012) . 9
Figure 1.4: Total and per capita healthcare spending by country (2012) .. 12
Figure 1.5: Healthcare expenditure per capita by country (EU28+2 2012) .. 14
Figure 1.6: Adult social care expenditures by local authorities (England 2013) . 15
Figure 1.7: Healthcare expenditure per capita by country (EU28+2 2012) .. 16
Figure 2.1: Analogue and digital telecare systems (EU 28+2 2013) 21
Figure 2.2: Adoption of telecare services per country (EU 28+2 2013).. 22
Figure 2.3: Neat NEO telecare device .. 23
Figure 2.4: The telecare value chain .. 24
Figure 2.5: Leading providers of telecare equipment (EU 28+2 2013) .. 25
Figure 2.6: Leading telecare solution providers per country (EU 28+2 2013). 26
Figure 2.7: Overview of telecare solution providers (EU 28+2 2013) .. 27
Figure 2.8: CareTech's CareIP telecare system .. 30
Figure 3.1: Next-generation telecare solutions by segment (EU 28+2 2013) . 39
Figure 3.2: Adoption of activity monitoring solutions per country (EU 28+2 2013) . 40
Figure 3.3: Examples of mobile telecare devices 41
Figure 3.4: Care@Home activity monitoring solution 43
Figure 3.5: Compliance monitoring solution form factors .. 44
Figure 3.6: Overview of the next-generation telecare value chain .. 45
Figure 3.7: Overview of the next-generation telecare landscape 46
Figure 3.8: Next-generation telecare solution providers . 47
Figure 3.9: The Evondos E300 Automatic Medicine Dispenser .. 50
Figure 3.10: Medido medication dispensers . 54
Figure 3.11: The Easypod injector and the Easypod connect transmitter . 60
Figure 3.12: Numera Libris and Numera Home Hub . 62
Figure 3.13: Vivago CARE 8001 watch . 66
Figure 4.1: Adoption of telehealth services per country (EU 28+2 2013) .. 69
Figure 4.2: Connected medical devices and the provision of care 70
Figure 4.3: Telehealth hub form factors 71
Figure 4.4: Overview of the telehealth value chain . 73
Figure 4.5: New players enter the telehealth market . 75
Figure 4.6: Telehealth solution providers 77
Figure 4.7: HealthGO+ and HealthGO Mini by eDevice . 86
Figure 4.8: The Twitoo telehealth hub .. 89
Figure 4.9: Medic4All's WristClinic monitoring device .. 90
Figure 5.1: Analogue and digital telecare systems (EU 28+2 2013-2019) . 106
Figure 5.2: Cellular connections in the connected care market (EU 28+2 2013-2019) .. 108
Figure 5.3: Connected care systems (EU 28+2 2013-2019) . 114
Figure 5.4: Traditional telecare systems (EU 28+2 2013-2019) .. 115
Figure 5.5: Next-generation telecare systems (EU 28+2 2013-2019) .. 117
Figure 5.6: Telehealth systems (EU 28+2 2013-2019) . 118
Figure 5.7: Connected care market revenues (EU 28+2 2013-2019) .. 119
Figure 5.8: Traditional telecare market revenues (EU 28+2 2013-2019) 120
Figure 5.9: Next-generation telecare market revenues (EU 28+2 2013-2019) 120
Figure 5.10: Telehealth market revenues (EU 28+2 2013-2019) 121

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Personal mobility devices such as wheelchairs, mobility scooters, and stair lifts have witnessed significant growth in revenue and volume in the past few years. A personal mobility device is either a manual ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.